Future Health GCC launched its state-of-the-art cord blood banking facility in Dubai Healthcare City in December representing a major step forward in healthcare for families across the region. This facility is designed to provide parents with the opportunity to store their newborns umbilical cord blood, which could be used in the future to treat a range of serious health conditions.
Cord blood is collected immediately after birth from the umbilical cord and placenta. This process is safe, non-invasive, and does not pose any risk to the mother or baby. The stored cord blood contains stem cells that have the potential to treat various diseases, such as certain types of cancers and blood disorders. Unlike traditional stem cell sources, cord blood is easier to collect and store, making it an attractive option for families looking to safeguard their children's future health.
Future Health GCC is part of the globally recognized Future Health Group, which has been serving the UAE for over ten years. The newly launched facility in Dubai is equipped with advanced technology to ensure the highest standards of storage and safety for cord blood. This marks an important milestone in the region's healthcare landscape, offering families a valuable resource for future medical needs.
"We are excited to offer this service to families in the UAE," said Ahmad Al Ahmad, CEO of Future Health GCC. "In addition to storing cord blood, we are also introducing new technology to store exosomes derived from cord blood, expanding treatment possibilities for the future."
The launch of Future Health GCCs facility not only enhances healthcare options for families but also opens up new possibilities for medical research and treatment development in the region. For more information, please visit www.futurehealthbiobank.com/ae-en